VIATRIS INC (VTRS)

US92556V1061 - Common Stock

13.37  +0.12 (+0.91%)

After market: 13.35 -0.02 (-0.15%)

News Image
14 days ago - Market News Video

YieldBoost VTRS To 8.9% Using Options

News Image
18 days ago - Chartmill

These S&P500 stocks have an unusual volume in today's session

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

News Image
18 days ago - Chartmill

Top S&P500 movers in Thursday's session

Thursday's session: top gainers and losers in the S&P500 index

News Image
20 days ago - Viatris Inc.

Viatris Announces Third Quarter 2024 Dividend

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share...

News Image
a month ago - Viatris Inc.

Viatris Named to Forbes' World's Top Companies for Women 2024 List

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' World's Top Companies for Women...

News Image
a month ago - Market News Video

XPO Larger Than S&P 500 Component Viatris

News Image
a month ago - Market News Video

Avangrid Larger Than S&P 500 Component Viatris

News Image
a month ago - Market News Video

AECOM Larger Than S&P 500 Component Viatris

News Image
a month ago - Viatris Inc.

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

/PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreement with Lexicon...

News Image
2 months ago - Viatris Inc.

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan...

News Image
2 months ago - Viatris Inc.

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024....

News Image
2 months ago - Viatris Inc.

Viatris Announces the Pricing Terms of Maximum Tender Offer

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the pricing terms of the previously announced cash tender offer (the...

News Image
2 months ago - Viatris Inc.

Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the early tender results of the previously announced cash tender offer...

News Image
2 months ago - Viatris Inc.

Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its third quarter 2024 financial results on Thursday, November 7, 2024, before the open of the U.S....

News Image
3 months ago - Viatris Inc.

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today that the previously announced cash tender offers (the "Any and All...

News Image
3 months ago - Viatris Inc.

Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the pricing terms of the previously announced cash tender offers (the...

News Image
3 months ago - Viatris Inc.

Viatris Announces Cash Tender Offers for Certain Outstanding Notes

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today that it and its subsidiaries, Mylan Inc. ("Mylan") and Utah Acquisition...

News Image
3 months ago - Viatris Inc.

Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, presented today the results of one of its Phase 2 studies* of cenerimod (ACT-333441)....

News Image
3 months ago - The Motley Fool

3 Top Value Stocks to Buy Right Now

Value stocks offer potential for significant returns in today's overheated market.

News Image
3 months ago - Market News Video

Wednesday Sector Laggards: Materials, Healthcare

News Image
3 months ago - Market News Video

YieldBoost VTRS From 4.2% To 7.2% Using Options

News Image
4 months ago - Yahoo Finance

Why Viatris Stock Is Jumping Today

Investors are applauding the healthcare company's improving growth story.

News Image
4 months ago - The Motley Fool

Why Viatris Stock Is Jumping Today

Investors are applauding the healthcare company's improving growth story.

News Image
4 months ago - Viatris Inc.

Viatris Reports Second Quarter Financial Results for 2024

/PRNewswire/ -- Strong Results Demonstrate Power of Company's Diversification, Execution and Growing Base Business Total Revenues of $3.8 Billion and...

News Image
4 months ago - Viatris Inc.

Viatris Announces Second Quarter 2024 Dividend

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on August 5, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for...

News Image
4 months ago - The Motley Fool

3 Surprisingly Underrated Stocks to Buy Right Now

These stocks arguably deserve more respect from investors.